Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Faith Donaghey"'
Autor:
Christopher Chin, Faith Donaghey, Katherine Helming, Morgan McCarthy, Stephen Rogers, Nicanor Austriaco
Publikováno v:
Microbial Cell, Vol 1, Iss 2, Pp 58-63 (2014)
Caspofungin was the first member of a new class of antifungals called echinocandins to be approved by a drug regulatory authority. Like the other echinocandins, caspofungin blocks the synthesis of β(1,3)-D-glucan of the fungal cell wall by inhibitin
Externí odkaz:
https://doaj.org/article/43a2e73a4e844421bb568a8e908c0c92
Autor:
Damien Z. Soghoian, Bruce D. Walker, Faith Donaghey, Michael S. Seaman, Srinika Ranasinghe, Madelene Lindqvist, Daniel Kaufmann, Mary Carrington, Musie Ghebremichael, Filippos Porichis
Publikováno v:
Journal of Virology. 90:2208-2220
Antigen-specific CD4 + T helper cell responses have long been recognized to be a critical component of effective vaccine immunity. CD4 + T cells are necessary to generate and maintain humoral immune responses by providing help to antigen-specific B c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a01ecd0fbc9c75be1de6228c032d80f
https://doi.org/10.1128/jvi.02278-15
https://doi.org/10.1128/jvi.02278-15
Autor:
Christopher, Chin, Faith, Donaghey, Katherine, Helming, Morgan, McCarthy, Stephen, Rogers, Nicanor, Austriaco
Publikováno v:
Microbial Cell
Caspofungin was the first member of a new class of antifungals called echinocandins to be approved by a drug regulatory authority. Like the other echinocandins, caspofungin blocks the synthesis of β(1,3)-D-glucan of the fungal cell wall by inhibitin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fe2fd45a80475fe0774536c5eb0929be
https://pubmed.ncbi.nlm.nih.gov/28357223
https://pubmed.ncbi.nlm.nih.gov/28357223
Publikováno v:
Open Forum Infectious Diseases
Background Hepatitis C virus infection (HCV) is a significant health concern in the United States, impacting an estimated 3 million people. Adults born between 1945 and 1965 (“baby boomers”) are 5 times more likely to have HCV infection compared
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd83c9f0911867b6dec5833484222bb8
http://europepmc.org/articles/PMC6808946
http://europepmc.org/articles/PMC6808946